This Startup Is Trying To Tackle The Problem Of Antibiotic Resistance
Day Zero Diagnostics reduces infectious disease identification time to mere hours to ensure the correct antibiotic course
Day Zero Diagnostics has a process that identifies what’s ailing you quickly and efficiently, so doctors know exactly which type of antibiotic to put you on. The startup developed a test that can identify the specific bacterial strain causing an illness in a matter of hours.
The issue of antibiotic resistance isn’t just how strong the resistance of microbes are but also a factor of time—sometimes in life or death terms. Imagine you’re really sick and you go to urgent care for treatment. The first course of broad-spectrum antibiotics doesn’t work, so you’re put on a more targeted course, and that doesn’t work. As the clock is ticking and your condition goes from worse to life-threatening, there’s still another course you get put on. It’s a process of elimination that can prove deadly.
The benefits of Day Zero Diagnostics’ approach, aside from avoiding an escalating illness, are many. Part of the problem with antibiotic resistance is that diseases evolve after they’ve been exposed to antibiotics, which is why it seems we need stronger and stronger doses and formulas just to get rid of a strain of strep. Reducing the frequency of use of broad-spectrum formulas for more targeted formulas keeps more antibiotics out of our systems and environment.
Before you start filling up your calendars with conferences to spark your business innovation and personal growth this year, add CXI 2018 conference to your wish list! For its 12th year running, PSFK is hosting an intimate conference where emerging pioneers and established experts will take the stage to discuss all things innovation around the new consumer experience.
Jared is partner at Pioneer Fund, a a venture fund that pools capital and expertise from 170+ Y Combinator alumni to make diversified investments in select YC companies. He is also founder and CEO of Crowd Med, a company that has raised over $4M in venture capital to date from several top-tier Silicon Valley venture funds to solve difficult medical cases.
Bobby Jones, Chief Marketing Officer at Peace First and co-author of Good Is The New Cool, shares his guidelines for marketing to a new generation of socially conscious consumers